Access to the PPM Journal and newsletters is FREE for clinicians.
Signup for PPM

All Hormone Therapy Articles

Dysmenorrhea, or menstrual pain, occurs in up to 90% of women and can have a detrimental effect on quality of life as symptoms become severe.1,2 Primary dysmenorrhea is characterized by pain without underlying pathology. Secondary dysmenorrhea refers to menses precipitated by an underlying pathology or a different medical condition.
Emerging and potential uses for neurosteroids, human chorionic gonadotropin, corticosteroids, oxytocin, nandrolone, and other hormone therapies for pain.
Editors answer readers questions. This month: how to initiate hormones in pain patients
A special set of neurohormones with pain-related functions, which if tapped for their intrinsic use, may diminish the need for opioids.
Testosterone replacement has been around since the 1970s. However, there has been a sharp increase in the number of prescriptions for testosterone in the past decade. Between 2000 and 2011, for example, the United States saw a 4-fold increase in testosterone use among men, many of whom had normal levels of testosterone.1
America’s growing shortage of pain specialists, and now primary care physicians, is affecting the availability of pain treatment in many rural communities. This has become true in one rural community in Chino Valley, Arizona, approximately 90 miles northwest of Phoenix, where the primary care physicians are being tasked to become experts in chronic pain management.
Dr. Forest Tennant answers readers questions about hormone therapy and laboratory values.
Article examines hormone testing and replacement as an essential component of chronic pain management.
A letter from a reader of Practical Pain Management on the use of human chorionic gonadotropic (HCG) in the care of chronic pain patients. A pain expert responds.
In 2011, the FDA took action against seven companies marketing over-the-counter human chorionic gonadotropin (HCG) products that were labeled “homeopathic” for weight loss. This is good for pain practitioners wanting to use HCG for pain treatment. Dr. Tennant explain why.
Letter to the Editor from Practical Pain Management about using human chorionic gonadotropin (HCG) in the treatment of chronic pain.
The effect of severe, persistent pain on the hormone system is profoundly negative. If the patient’s hormone system is not kept homeostatic and balanced, the patient with pain will rapidly age and deteriorate. Consequently, the achievement of hormonal balance—not too high or too low—has to be a primary goal of treatment.
Adequate testosterone serum levels are required in males and females not just for libido and sexual function but also for cellular growth, healing, maintenance of muscle mass and bone, and central nervous system maintenance of opioid receptors, blood- brain barrier, and dopamine-norepinephrine activity.
When severe pain and stimulation of the pituitary-adrenal-gonadal axis goes unabated over time, exhaustion of some adrenal compounds may develop and, left untreated, may pose a combination of problems.
HCG has great potential as an adjunct in the treatment of severe, chronic pain patients—particularly in those who demonstrate hormonal deficiencies or who show progressive wasting and deterioration.
Since testosterone assists opioids in crossing the blood brain barrier and helps activate a number of central receptors and neurochemicals systems, it is a judicious, ethical, and clinically necessary practice to replace testosterone in female chronic opioid patients—subject to informed consent.
close X